Aclaris Therapeutics, Inc. (ACRS)
3.44
-0.06
(-1.71%)
USD |
NASDAQ |
Nov 20, 16:00
3.445
0.00 (0.00%)
After-Hours: 20:00
Aclaris Therapeutics Price to Book Value : 3.111 for Nov. 20, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2026 | 3.111 |
| November 19, 2026 | 3.165 |
| November 18, 2026 | 3.165 |
| November 17, 2026 | 3.056 |
| November 16, 2026 | 3.260 |
| November 13, 2026 | 3.545 |
| November 12, 2026 | 3.617 |
| November 11, 2026 | 3.924 |
| November 10, 2026 | 3.753 |
| November 09, 2026 | 3.834 |
| November 06, 2026 | 3.526 |
| November 05, 2026 | 3.264 |
| November 04, 2026 | 3.328 |
| November 03, 2026 | 3.382 |
| November 02, 2026 | 3.436 |
| October 30, 2026 | 3.590 |
| October 29, 2026 | 3.608 |
| October 28, 2026 | 3.581 |
| October 27, 2026 | 3.427 |
| October 26, 2026 | 3.427 |
| October 23, 2026 | 3.391 |
| October 22, 2026 | 3.463 |
| October 21, 2026 | 3.445 |
| October 20, 2026 | 3.409 |
| October 19, 2026 | 3.147 |
| Date | Value |
|---|---|
| October 16, 2026 | 2.966 |
| October 15, 2026 | 3.156 |
| October 14, 2026 | 3.056 |
| October 13, 2026 | 3.138 |
| October 12, 2026 | 3.255 |
| October 09, 2026 | 3.463 |
| October 08, 2026 | 3.427 |
| October 07, 2026 | 3.074 |
| October 06, 2026 | 3.346 |
| October 05, 2026 | 3.861 |
| October 02, 2026 | 3.970 |
| October 01, 2026 | 3.988 |
| September 30, 2026 | 4.756 |
| September 29, 2026 | 5.926 |
| September 28, 2026 | 6.094 |
| September 25, 2026 | 5.780 |
| September 24, 2026 | 6.038 |
| September 23, 2026 | 5.904 |
| September 22, 2026 | 6.420 |
| September 21, 2026 | 6.252 |
| September 18, 2026 | 6.173 |
| September 17, 2026 | 6.061 |
| September 16, 2026 | 5.971 |
| September 15, 2026 | 6.201 |
| September 14, 2026 | 6.330 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.464 |
| Corcept Therapeutics, Inc. | 8.345 |
| Veru, Inc. | 1.166 |
| Johnson & Johnson | 7.986 |
| Eli Lilly & Co. | 31.48 |
Price to Book Value Related Metrics
| PS Ratio | 73.04 |
| Price | 3.44 |
| Earnings Yield | -17.15% |
| Market Cap | 518.84M |